HIGHLIGHTS
SUMMARY
Of the included eleven studies, five studies compared Drospirenone and Ethinylestradiol Tablets (II) with placebo or active control drugs, two studies compared Drospirenone and Ethinylestradiol Tablets (II) flexible extended regimen and conventional 24/4-day regimens, and four studies were single-arm studies of Drospirenone and Ethinylestradiol Tablets (II). Of single-arm studies on dysmenorrhea treatment with drospirenone and ethinylestradiol tablets (II) Number of days of pelvic pain Four single-arm studies investigated Drospirenone and Ethinylestradiol Tablets (II) conventional 24/4-day regimen on dysmenorrhea treatment. The severity of menstrual pain was assessed using . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.